Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Prediction: This Beaten-Down Stock Could Double in The Next 5 Years
Prediction: This Beaten-Down Stock Could Double in The Next 5 Years

Despite making significant clinical progress, CRISPR Therapeutics (NASDAQ: CRSP) has been struggling financially in the past three years. The company's shares are down by 24% over this period, while

Massive News for UnitedHealth Stock Investors!
Massive News for UnitedHealth Stock Investors!

UnitedHealth (NYSE: UNH) is reportedly under criminal investigation, and in this video, I will discuss what that could mean for investors.

*Stock prices used were the afternoon prices of May 14

The Top Tech Stock Winners From Trump's $600 Billion Saudi Arabian Deal
The Top Tech Stock Winners From Trump's $600 Billion Saudi Arabian Deal

Following a visit to Saudi Arabia last week, President Donald Trump announced that the kingdom has pledged to invest $600 billion in deals with U.S. companies. The agreement includes $142 billion in

Tesla Started the Ball Rolling and It Could Mean a 9,000% Growth Driver for These 3 Dividend Stocks
Tesla Started the Ball Rolling and It Could Mean a 9,000% Growth Driver for These 3 Dividend Stocks

Tesla (NASDAQ: TSLA) is a polarizing stock thanks partly to its larger-than-life CEO, Elon Musk. But Musk's theatrical flare literally helped to create the electric vehicle (EV) industry. Now, with

3 Magnificent Stocks That Are Passive Income Machines
3 Magnificent Stocks That Are Passive Income Machines

Make money without even trying: That's what passive income is all about. But good investment alternatives are required to make this "easy" money.

Three Motley Fool contributors believe they have

Why Viking Therapeutics Stock Bumped 3% Higher Today
Why Viking Therapeutics Stock Bumped 3% Higher Today

A major C-suite change at a potential competitor was a key factor behind the rise of Viking Therapeutics (NASDAQ: VKTX) stock on Friday, which closed the trading session 3% higher. That figure was

Why Is Everyone Talking About UnitedHealth Group Stock?
Why Is Everyone Talking About UnitedHealth Group Stock?

In this video, I will talk about UnitedHealth Group (NYSE: UNH) and explain why the stock has crashed 50% in the past month. Watch the short video to learn more, consider subscribing, and click the

AMD Stock Investors Got Flooded With Amazing News This Week
AMD Stock Investors Got Flooded With Amazing News This Week

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.

Why Is UnitedHealth Stock Crashing, and Is It a Buying Opportunity?
Why Is UnitedHealth Stock Crashing, and Is It a Buying Opportunity?

UnitedHealth (NYSE: UNH) made several massive announcements during an investor update that crashed the stock price.

*Stock prices used were the afternoon prices of May 12, 2025. The video was

Down 9%, Should You Buy the Dip on AT&T?
Down 9%, Should You Buy the Dip on AT&T?

AT&T's (NYSE: T) stock hit a 52-week high of $29.03 per share on April 3. That represented a gain of more than 60% over the previous year. Investors appear to have embraced AT&T for three reasons:

Why Is Everyone Talking About UnitedHealth Stock?
Why Is Everyone Talking About UnitedHealth Stock?

UnitedHealth (NYSE: UNH) is capturing headlines for all the wrong reasons.

*Stock prices used were the afternoon prices of May 13, 2025. The video was published on May 15, 2025.

Continue reading

So

Here's How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend Income
Here's How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend Income

Looking for income? You might want to check out Pfizer (NYSE: PFE). This big drugmaker has been a favorite for income investors for years. However, its dividend is arguably more attractive than

UnitedHealth Is One of the Worst S&P 500 Stocks In 2025. Here's Why It's Having an Even Bigger Impact on the Dow Jones.
UnitedHealth Is One of the Worst S&P 500 Stocks In 2025. Here's Why It's Having an Even Bigger Impact on the Dow Jones.

Healthcare insurance giant UnitedHealth Group (NYSE: UNH) has seen its stock go from a stable stalwart to a falling knife, seemingly overnight. The stock's price crashed 22.4% on April 17 in

2 Dividend Stocks to Double Up on Right Now
2 Dividend Stocks to Double Up on Right Now

If you're looking to boost your passive income, Coca-Cola (NYSE: KO) and AT&T (NYSE: T) are solid dividend stock choices right now. These companies generate repeat revenue from consumers throughout

Down 59%, Is UnitedHealth Group Stock a Buy on the Dip?
Down 59%, Is UnitedHealth Group Stock a Buy on the Dip?

Over the past year, America's typically predictable health insurance industry has been exciting in ways that investors hardly appreciate. In a nutshell, healthcare expenses have been outpacing the

Why UnitedHealth Stock Is Imploding Today
Why UnitedHealth Stock Is Imploding Today

Shares of UnitedHealth Group (NYSE: UNH) are falling on Thursday. The company's stock has plummeted 15% as of 11:33 a.m. ET but lost as much as 19.2% earlier in the day. The collapse comes as the

Massive News For AMD and Nvidia Stock Investors
Massive News For AMD and Nvidia Stock Investors

In this video, I will cover the recent updates regarding Advanced Micro Devices (NASDAQ: AMD), Nvidia, and Intel. Watch the short video to learn more, consider subscribing, and click the special

What Most-Favored-Nation Status Could Mean for Pharmaceutical Stocks
What Most-Favored-Nation Status Could Mean for Pharmaceutical Stocks

Recently, the Trump Administration signed an executive order to lower the prices Americans pay for prescription drugs. According to the administration, the U.S. funds roughly 75% of global

Is Axsome Therapeutics Stock Worth the Risk? A Comprehensive Analysis
Is Axsome Therapeutics Stock Worth the Risk? A Comprehensive Analysis

Explore the exciting world of Axsome Therapeutics (NASDAQ: AXSM) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market

Why Exelixis Stock Is Skyrocketing Today
Why Exelixis Stock Is Skyrocketing Today

Shares of Exelixis (NASDAQ: EXEL) were skyrocketing 18.5% higher at 11:05 a.m. ET on Wednesday. The huge gain came after the drugmaker announced its 2025 first-quarter results Tuesday evening.

House Democrats Criticize Donald Trump's "Corrupt" Connections to Cryptocurrency. Should Investors Be Worried?
House Democrats Criticize Donald Trump's "Corrupt" Connections to Cryptocurrency. Should Investors Be Worried?

It's no secret that President Donald Trump is heavily invested in cryptocurrencies ranging from Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) to his Official Trump (CRYPTO: TRUMP) meme coin on

Why Weight-Loss Developer Stocks Tumbled on Tuesday
Why Weight-Loss Developer Stocks Tumbled on Tuesday

Makers of weight-loss drugs, the hottest segment of the pharmaceutical market just now, weren't looking so hot on the stock exchange Tuesday. A pronouncement from President Trump about the category

TSMC Delivered Amazing News for AMD and Nvidia Stock Investors
TSMC Delivered Amazing News for AMD and Nvidia Stock Investors

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD) and Nvidia (NASDAQ: NVDA) after Taiwan Semiconductor Manufacturing (NYSE: TSM) reported its monthly revenue

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years
2 Monster Stocks in the Making to Buy Now and Hold for 10 Years

Investing in promising companies before their stock prices soar is an excellent recipe for earning life-changing returns. However, with hundreds of companies vying for investors' attention

Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO
Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president, in addition to his current role as chief